Top 20 Remote Monitoring & Wearable Health Technology Providers 2026

This report forms part of the Ranking News Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, diagnostics providers, laboratories, precision medicine platforms, pharmaceutical services providers, medical technology firms, and healthcare systems across global healthcare markets.

Remote monitoring and wearable health technology providers occupy a growing position within medical technology and digital care infrastructure. These companies develop the connected devices, physiological sensors, wearable monitors, software platforms, cloud dashboards, and clinical workflows that allow patients, clinicians, caregivers, employers, and health systems to track health data outside traditional hospital and clinic settings.

Unlike general consumer electronics firms or wellness apps, the strongest remote monitoring and wearable health technology providers combine hardware reliability, clinical-grade sensing, regulatory compliance, data security, physician workflow integration, reimbursement relevance, and longitudinal patient engagement. Their products may monitor glucose, heart rhythm, oxygen saturation, blood pressure, sleep-disordered breathing, respiratory function, physical activity, temperature, cardiac status, medication adherence, post-acute recovery, and chronic disease risk.

The sector has expanded as healthcare shifts toward earlier intervention, home-based care, chronic disease management, hospital-at-home models, and consumer health awareness. Continuous glucose monitors, ambulatory ECG patches, pulse oximetry systems, connected respiratory devices, smart rings, remote monitoring platforms, and wearable sensors are increasingly used to bridge the gap between episodic clinical visits and continuous real-world health data.

This ranking identifies remote monitoring and wearable health technology providers whose platforms demonstrate sustained relevance across clinical monitoring, chronic care, consumer adoption, connected devices, care-team workflows, patient engagement, and health data infrastructure. Rather than focusing only on consumer popularity or device shipment volume, the objective is to recognize specific license-targetable firms whose platforms are structurally important to the future of connected healthcare.

Market Overview

The remote monitoring and wearable health technology market has expanded across several distinct segments. The first is clinical-grade chronic disease monitoring, led by continuous glucose monitoring companies such as Dexcom and Abbott. Continuous glucose monitoring has become one of the most commercially successful forms of wearable medical technology, supporting patients with diabetes and increasingly extending toward broader metabolic health applications. Abbott’s FreeStyle Libre franchise remains one of the largest platforms in this category, with reported quarterly CGM sales of approximately $1.9 billion in Q2 2025 and continued double-digit growth.

The second segment is cardiac monitoring. Companies such as iRhythm Technologies, Philips / BioTelemetry, Boston Scientific, Medtronic, and Preventice Solutions provide ambulatory ECG, implantable cardiac monitoring, rhythm detection, and remote cardiac follow-up. iRhythm’s Zio platform has become one of the best-known long-term continuous ECG monitoring services, and the company reported large real-world analyses involving more than one million patients using Zio long-term continuous monitoring.

The third segment is hospital and post-acute remote patient monitoring. Masimo, Philips, GE HealthCare, Baxter / Hillrom, Medtronic, Current Health, Biofourmis, and Cadence support remote vital-sign monitoring, command centers, hospital-at-home programs, connected care, and chronic disease programs. Masimo’s Patient SafetyNet and Radius VSM platforms, for example, have been deployed by health systems for centralized remote surveillance of general-care patients.

The fourth segment is respiratory and sleep monitoring. ResMed is one of the most important companies in this area, with connected CPAP and respiratory care platforms. Its 2025 annual report described cloud-based patient management and engagement platforms such as AirView and myAir, enabling remote monitoring, troubleshooting, device setting changes, and automated patient coaching.

The fifth segment is consumer wearable health technology. Oura, WHOOP, Fitbit / Google, Apple, Garmin, Withings, and Samsung Health all play roles in sleep tracking, recovery, heart rate, activity, temperature, ECG, oxygen saturation, women’s health, and wellness analytics. Oura raised more than $900 million in 2025 to accelerate global expansion and health innovation, while WHOOP raised $575 million at a reported $10.1 billion valuation despite regulatory scrutiny around blood pressure functionality.

Industry Trend — 2026

The remote monitoring and wearable health technology industry in 2026 is shaped by five major trends: continuous data, chronic disease management, hospital-at-home adoption, consumer-to-clinical convergence, and AI-enabled risk prediction.

First, continuous data is becoming more valuable than episodic measurement. Glucose, heart rhythm, sleep, oxygen saturation, activity, respiratory patterns, and vital signs can now be measured over days, weeks, or months rather than only during clinic visits. This creates richer longitudinal datasets that can help identify deterioration, treatment response, adherence problems, and lifestyle patterns.

Second, chronic disease management is driving clinical adoption. Diabetes, hypertension, heart failure, chronic obstructive pulmonary disease, sleep apnea, arrhythmia, obesity, and cardiometabolic disease are increasingly supported by connected devices and remote monitoring workflows. Remote patient monitoring is projected to remain a high-growth market, with one 2026 market report estimating the global market at $63.75 billion and forecasting growth to $111.93 billion by 2030.

Third, hospital-at-home and post-acute care models are increasing demand for reliable remote vital-sign monitoring. Health systems need connected devices, data dashboards, alerting systems, and escalation workflows to safely manage patients outside traditional inpatient beds. Companies with clinical-grade monitoring, workflow integration, and enterprise deployment capability are better positioned than simple wellness-device brands.

Fourth, consumer and clinical wearables are converging. Oura, WHOOP, Apple, Fitbit, Garmin, Withings, and Samsung increasingly produce health metrics that consumers use for wellness, preventive health, and self-management. However, regulatory boundaries remain important: WHOOP’s reported FDA friction over an unapproved blood pressure feature illustrates the tension between wellness features and medical device claims.

Fifth, AI-enabled interpretation is becoming a differentiator. The future of wearable health technology will depend less on collecting more raw data and more on detecting meaningful patterns, predicting risk, reducing false alarms, and integrating insights into clinician workflows. The strongest firms will combine validated sensors with software, clinical evidence, user engagement, and responsible data governance.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates as a remote patient monitoring provider, wearable health technology company, connected medical device manufacturer, ambulatory monitoring provider, digital biomarker platform, or clinical monitoring technology firm
• Provides products or services such as continuous glucose monitoring, wearable ECG, remote cardiac monitoring, pulse oximetry, sleep monitoring, respiratory monitoring, connected vital signs, smart rings, remote patient monitoring dashboards, or hospital-at-home monitoring
• Maintains meaningful institutional scale through regulatory clearances, commercial adoption, health-system relationships, payer coverage, consumer user base, clinical evidence, or global distribution
• Demonstrates relevance in chronic disease management, preventive health, post-acute care, hospital-at-home, consumer health tracking, cardiac monitoring, diabetes care, respiratory care, or clinical workflow integration
• Represents a specific license-targetable operating organization, rather than a broad ecosystem category, trade association, informal network, or generic technology label

Pure fitness-only brands, wellness apps without meaningful health-monitoring technology, early-stage sensor startups without sufficient operating scale, software-only analytics vendors without monitoring infrastructure, and hospital systems without standalone monitoring platform identity were generally excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term valuation alone. Key factors considered include:

• Scale and maturity of remote monitoring or wearable health platform
• Clinical relevance and strength of physiological sensing technology
• Regulatory clearance, clinical evidence, and patient safety governance
• Integration with clinicians, health systems, payers, employers, caregivers, or consumer health ecosystems
• Strength in high-impact categories such as diabetes, cardiac monitoring, sleep, respiratory disease, chronic care, and hospital-at-home
• Data infrastructure, cloud connectivity, AI analytics, and longitudinal health insights
• User engagement, adherence, device usability, and recurring platform economics
• Institutional stability, brand reputation, and long-term platform resilience

The objective of the ranking is to identify remote monitoring and wearable health technology providers whose platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 20 Remote Monitoring & Wearable Health Technology Providers 2026 ranking evaluates companies based on connected health technology, clinical monitoring relevance, wearable platform strength, enterprise adoption, consumer reach, regulatory maturity, and long-term institutional resilience.

The ranking universe consisted of approximately 150 remote monitoring and wearable health technology providers globally, from which 20 organizations were selected for inclusion.

Tier classifications reflect relative institutional positioning within the remote monitoring and wearable health technology sector and do not represent clinical recommendations, procurement advice, investment recommendations, or endorsement of any specific device or digital health service.

---

Tier I — Leading Remote Monitoring & Wearable Health Technology Providers

Dexcom

• Headquarters: San Diego, United States
• Founded: 1999
• Core focus: Continuous glucose monitoring, diabetes technology, metabolic health, remote glucose data sharing

Dexcom is one of the most important wearable medical technology providers globally and a leader in continuous glucose monitoring. Its CGM systems allow users, clinicians, and caregivers to monitor glucose trends continuously, supporting diabetes management and increasingly broader metabolic health use cases.

Dexcom’s strength lies in clinical-grade wearable sensing. Continuous glucose monitoring is one of the few wearable health technologies with deep medical adoption, payer relevance, physician workflow integration, and direct impact on chronic disease management. Dexcom’s Share remote monitoring system allows glucose information to be transmitted securely to designated followers, creating a connected care model for patients, caregivers, and families.

The company’s relevance extends beyond diabetes hardware. Dexcom operates a data ecosystem involving sensors, mobile apps, cloud connectivity, alerts, caregiver sharing, and integration with insulin delivery systems. This makes it central to the shift from episodic blood glucose testing toward continuous metabolic monitoring.

Despite periodic execution and product reliability concerns, Dexcom remains one of the most clinically established wearable health technology firms. Its CGM leadership, regulatory maturity, payer access, diabetes ecosystem, and remote data-sharing capability support its Tier I position.

Abbott

• Headquarters: Abbott Park, United States
• Founded: 1888
• Core focus: Continuous glucose monitoring, cardiovascular devices, diagnostics, connected chronic care

Abbott is one of the leading global providers of wearable and connected health technology, anchored by its FreeStyle Libre continuous glucose monitoring platform. The company’s broader medical technology portfolio also includes cardiovascular devices, diagnostics, neuromodulation, and connected chronic care systems.

Abbott’s strength lies in scale and accessibility. FreeStyle Libre has become one of the largest CGM platforms worldwide, helping expand continuous glucose monitoring beyond earlier specialist markets. Abbott reported strong diabetes care momentum in 2025, with FreeStyle Libre demand driving significant growth in its diabetes care division.

The company’s connected health relevance also extends to cardiology, diagnostics, and implantable technologies. Its ability to combine sensors, devices, clinical evidence, reimbursement access, and global distribution gives Abbott a major advantage over smaller wearable firms.

Abbott has also faced device-safety scrutiny, including a 2025 correction involving certain FreeStyle Libre 3 and Libre 3 Plus sensors due to potential inaccurate readings. Even so, its global CGM scale, medical device infrastructure, regulatory experience, and chronic disease relevance support its Tier I position.

iRhythm Technologies

• Headquarters: San Francisco, United States
• Founded: 2006
• Core focus: Ambulatory ECG monitoring, wearable cardiac patches, arrhythmia detection, cardiac data analytics

iRhythm Technologies is one of the leading remote cardiac monitoring providers, best known for its Zio long-term continuous ECG monitoring platform. The company combines wearable cardiac patches, data analytics, clinical reporting, and physician-facing workflow support to improve arrhythmia detection.

iRhythm’s strength lies in long-duration cardiac monitoring. Many arrhythmias are intermittent and may be missed by short Holter monitoring. iRhythm’s real-world analyses presented in 2025 drew on more than one million patients and emphasized the clinical value of longer monitoring periods for detecting actionable arrhythmias.

The company’s platform is highly relevant because cardiac rhythm disorders are common, clinically significant, and often underdetected. Wearable ECG monitoring can support diagnosis of atrial fibrillation, supraventricular tachycardia, pauses, heart block, and other rhythm abnormalities.

iRhythm’s focused cardiac monitoring platform, clinical evidence base, data scale, physician adoption, and clear diagnostic use case support its position among leading remote monitoring providers.

ResMed

• Headquarters: San Diego, United States
• Founded: 1989
• Core focus: Sleep apnea, respiratory care, connected CPAP devices, cloud-based patient management

ResMed is one of the most important connected health technology providers in sleep and respiratory care. Its devices and software platforms support sleep apnea treatment, respiratory therapy, home care, provider workflow, and remote patient engagement.

ResMed’s strength lies in connected respiratory care. Sleep apnea and chronic respiratory conditions require ongoing adherence, device settings, troubleshooting, coaching, and clinician oversight. ResMed’s cloud-based AirView and myAir platforms support remote monitoring, over-the-air troubleshooting, device setting changes, and automated patient coaching.

The company has built a durable ecosystem around devices, masks, software, data, and patient engagement. This gives ResMed a strong position in long-term home-based therapy, where adherence and monitoring are central to clinical and commercial success.

ResMed’s respiratory device leadership, connected platform infrastructure, provider adoption, home-care relevance, and global scale support its Tier I position.

Masimo

• Headquarters: Irvine, United States
• Founded: 1989
• Core focus: Pulse oximetry, patient monitoring, wearable sensors, hospital remote surveillance

Masimo is a leading patient monitoring technology company known for noninvasive monitoring, pulse oximetry, sensor technology, hospital monitoring systems, and wearable vital-sign platforms. Its technologies are used across operating rooms, intensive care units, general hospital wards, home monitoring, and remote surveillance workflows.

Masimo’s strength lies in clinical-grade physiological monitoring. The company built its reputation around pulse oximetry and has expanded into broader noninvasive monitoring, wearable sensors, and connected patient safety systems. Masimo describes itself as a global medical technology company developing noninvasive patient monitoring technologies, medical devices, and sensors.

Its remote monitoring relevance is illustrated by health-system deployments of Radius VSM and Patient SafetyNet for centralized surveillance of general-care patients. University Hospitals’ 2025 deployment described system-wide continuous monitoring for adult and pediatric patients, wirelessly connected to Masimo Patient SafetyNet.

Masimo’s monitoring technology, hospital integration, sensor expertise, and patient safety platform support its position among leading remote monitoring providers.

---

Tier II — Established Remote Monitoring & Wearable Health Technology Providers

(Alphabetical order)

Apple

• Headquarters: Cupertino, United States
• Founded: 1976
• Core focus: Consumer wearables, Apple Watch, ECG, heart rhythm notifications, fitness and health data

Apple is one of the most influential wearable health technology providers through Apple Watch and the broader Apple Health ecosystem. While Apple is not a pure medical device company, its wearable platform has brought heart rate, ECG, irregular rhythm notifications, activity tracking, fall detection, temperature sensing, sleep tracking, and health data aggregation to a massive consumer base.

Apple’s strength lies in user adoption and ecosystem integration. Health data collected through Apple Watch can be shared with users, apps, researchers, and in selected cases healthcare providers. The company’s consumer reach gives it a unique ability to normalize wearable health tracking at population scale.

Apple’s challenge is that many features remain wellness-oriented rather than fully clinical diagnostic tools. However, its regulatory-cleared ECG functionality, atrial fibrillation notification features, and health data ecosystem give it clear relevance in remote and wearable health technology.

Apple’s installed base, consumer trust, software ecosystem, and ability to bridge wellness and medical-grade features support its inclusion among established providers.

Biofourmis

• Headquarters: Boston, United States
• Founded: 2015
• Core focus: Remote patient monitoring, digital therapeutics, hospital-at-home, chronic disease management

Biofourmis is a remote monitoring and digital therapeutics platform focused on clinical-grade home monitoring, chronic disease programs, hospital-at-home support, and digital biomarkers. Its platform combines wearable sensors, analytics, care pathways, and clinician-facing dashboards.

Biofourmis’ strength lies in disease-specific remote care programs. Remote monitoring becomes more valuable when it is connected to clinical protocols, escalation pathways, medication adjustment, and care-team workflows. Biofourmis has positioned itself around these higher-acuity use cases.

The company is particularly relevant in cardiology, oncology, post-acute care, and complex chronic disease management. Its platform reflects the movement from passive data collection toward algorithm-supported care delivery.

Biofourmis’ remote monitoring technology, clinical workflow orientation, and chronic care relevance support its inclusion among established providers.

Boston Scientific

• Headquarters: Marlborough, United States
• Founded: 1979
• Core focus: Cardiac rhythm management, implantable devices, remote cardiac monitoring, cardiovascular technology

Boston Scientific is an important remote monitoring provider through its cardiac rhythm management and implantable device portfolio. Pacemakers, defibrillators, and related cardiac devices increasingly depend on remote monitoring systems that transmit device and patient status information to clinicians.

Boston Scientific’s strength lies in implantable cardiac monitoring and cardiovascular device integration. Remote monitoring is especially important in rhythm management because patients may require ongoing surveillance for arrhythmias, device function, battery status, and therapy delivery.

The company’s broader cardiovascular portfolio gives it strong physician relationships and clinical infrastructure. While Boston Scientific is not a wearable consumer platform, it remains highly relevant in clinical remote monitoring for patients with implanted cardiac devices.

Boston Scientific’s cardiac rhythm management base, cardiovascular technology platform, and remote follow-up relevance support its inclusion among established providers.

Cadence

• Headquarters: New York, United States
• Founded: 2021
• Core focus: Remote patient monitoring, chronic disease management, health-system virtual care

Cadence is a specialist remote patient monitoring platform focused on chronic disease management through connected devices, clinical monitoring, and health-system partnerships. Its model supports conditions such as hypertension, diabetes, heart failure, and chronic obstructive pulmonary disease.

Cadence’s strength lies in health-system integration. Many remote monitoring programs fail when device data is not connected to clinical workflows or care teams. Cadence positions itself around provider-partnered monitoring, helping health systems extend chronic care beyond the clinic.

The company’s platform reflects the shift from device-centric monitoring toward service-enabled chronic disease management. It combines connected measurements, clinical oversight, and escalation workflows.

Cadence’s chronic care focus, provider integration, and remote monitoring service model support its inclusion among established providers.

Current Health / Best Buy Health

• Headquarters: Edinburgh / Boston
• Founded: 2015
• Core focus: Remote patient monitoring, hospital-at-home, home-based clinical data, care-at-home infrastructure

Current Health, part of Best Buy Health, is a remote patient monitoring and care-at-home platform supporting health systems, hospital-at-home programs, and home-based clinical monitoring. Its platform helps collect physiological data from patients outside hospital settings and support clinical oversight.

Current Health’s strength lies in care-at-home infrastructure. Hospital-at-home and post-acute monitoring require reliable device connectivity, patient support, data routing, escalation workflows, and integration with care teams. Current Health operates in this clinical infrastructure layer.

Best Buy Health’s ownership provides additional relevance through home services, logistics, and consumer technology support. Remote monitoring in the home depends not only on devices but also on installation, patient support, and operational reliability.

Current Health’s hospital-at-home relevance, connected monitoring platform, and Best Buy Health support infrastructure justify its inclusion among established providers.

Fitbit / Google

• Headquarters: Mountain View, United States
• Founded: Fitbit founded 2007; acquired by Google in 2021
• Core focus: Consumer wearables, activity tracking, heart rate, sleep, health data, wellness analytics

Fitbit, now part of Google, remains one of the most recognized consumer wearable health platforms. Its devices track activity, heart rate, sleep, oxygen saturation, stress, readiness, and other health-related metrics, supporting consumers seeking longitudinal wellness and fitness data.

Fitbit’s strength lies in consumer adoption and integration with Google’s software ecosystem. Although the platform has faced strong competition from Apple, Garmin, Oura, WHOOP, and Samsung, Fitbit remains a meaningful brand in wearable health technology.

The company’s clinical relevance is more limited than Dexcom, iRhythm, or ResMed, but its consumer reach and health data infrastructure remain important. Google’s AI and data capabilities may also support future health analytics if integrated responsibly.

Fitbit / Google’s wearable brand, health-tracking platform, consumer user base, and ecosystem potential support its inclusion among established providers.

Garmin

• Headquarters: Olathe, United States
• Founded: 1989
• Core focus: Wearable fitness technology, heart rate, sleep, activity, endurance health analytics

Garmin is a major wearable health and fitness technology provider, especially strong among athletes, endurance users, outdoor users, and performance-focused consumers. Its smartwatches and devices monitor heart rate, activity, sleep, training load, recovery, oxygen saturation, stress, and related health metrics.

Garmin’s strength lies in performance-oriented health data. While many of its products are wellness rather than medical devices, the company has deep credibility among users who value accurate activity, training, and physiological tracking.

The platform is relevant to preventive health and lifestyle management because activity, sleep, heart rate, and recovery data can influence long-term health behaviors. Garmin’s devices are also used in research, coaching, occupational wellness, and athletic medicine contexts.

Garmin’s wearable device portfolio, loyal user base, performance analytics, and global distribution support its inclusion among established providers.

Medtronic

• Headquarters: Dublin, Ireland / Operational headquarters: Minneapolis, United States
• Founded: 1949
• Core focus: Implantable cardiac devices, diabetes technology, remote monitoring, connected medical devices

Medtronic is a major remote monitoring provider through its implantable cardiac devices, diabetes technologies, neuromodulation platforms, and connected medical device ecosystem. Patients with pacemakers, defibrillators, insulin pumps, and other Medtronic devices often require remote follow-up, alerts, device data review, and clinician oversight.

Medtronic’s strength lies in clinical integration. Its remote monitoring platforms are embedded in specialist care pathways, particularly cardiology and diabetes care. Unlike consumer wearables, Medtronic’s monitoring systems are often tied directly to regulated therapeutic devices.

The company’s broad device portfolio also supports care continuity across cardiac rhythm management, heart failure, diabetes, and neurological conditions. Remote monitoring is increasingly part of how these devices deliver value after implantation or prescription.

Medtronic’s connected medical device portfolio, cardiac rhythm management scale, diabetes technology base, and clinical workflow integration support its inclusion among established remote monitoring providers.

Oura

• Headquarters: Oulu, Finland / San Francisco, United States
• Founded: 2013
• Core focus: Smart ring, sleep tracking, readiness, temperature, women’s health, consumer health insights

Oura is one of the leading consumer wearable health technology companies and the strongest brand in the smart ring category. Its ring tracks sleep, activity, temperature, stress, readiness, heart health-related metrics, and women’s health signals, creating a high-engagement wearable platform.

Oura’s strength lies in form factor and consumer engagement. Smart rings are less intrusive than watches and can support continuous monitoring during sleep and daily life. Oura has built a strong identity around sleep, recovery, and preventive health awareness.

The company raised more than $900 million in 2025 to accelerate global expansion and health innovation, reporting millions of members and broad use across individuals, researchers, healthcare providers, and organizations. It remains primarily a consumer health platform rather than a clinical medical device company, but its scale and health data relevance are significant.

Oura’s smart ring leadership, strong brand, consumer adoption, sleep and readiness analytics, and research relevance support its inclusion among established wearable health providers.

Philips

• Headquarters: Amsterdam, Netherlands
• Founded: 1891
• Core focus: Patient monitoring, connected care, BioTelemetry, hospital and ambulatory monitoring

Philips is a major remote monitoring and connected care provider through its patient monitoring systems, hospital infrastructure, ambulatory cardiac monitoring assets, and BioTelemetry platform. Its products support hospital monitoring, telehealth, cardiac monitoring, and care coordination.

Philips’ strength lies in clinical monitoring infrastructure. Hospitals require integrated monitoring systems, alarm management, central stations, and connected workflows. Philips has long been one of the major vendors in patient monitoring and connected care.

Its BioTelemetry business gives Philips additional relevance in ambulatory cardiac monitoring, including wearable ECG and remote rhythm monitoring services. This positions Philips across both inpatient and outpatient monitoring environments.

Philips has faced quality and regulatory challenges in respiratory care, but its monitoring and connected care infrastructure remain highly relevant. Its hospital installed base, BioTelemetry platform, and enterprise connected care capabilities support its inclusion among established providers.

---

Tier III — Specialist Remote Monitoring & Wearable Health Technology Providers

(Alphabetical order)

AliveCor

• Headquarters: Mountain View, United States
• Founded: 2011
• Core focus: Personal ECG, mobile cardiac monitoring, consumer heart rhythm detection

AliveCor is a specialist wearable and mobile cardiac monitoring company known for personal ECG devices and heart rhythm detection tools. Its Kardia devices allow users to capture ECG recordings and share rhythm data with clinicians.

AliveCor’s strength lies in consumer-accessible cardiac monitoring. Many patients with palpitations or suspected arrhythmias benefit from portable ECG capture outside clinical settings. The company’s devices provide a bridge between consumer health awareness and clinical rhythm documentation.

AliveCor’s personal ECG platform, consumer brand, and cardiac monitoring focus support its Tier III inclusion.

Biobeat

• Headquarters: Petah Tikva, Israel
• Founded: 2016
• Core focus: Wearable vital-sign monitoring, hospital and home monitoring, blood pressure, respiratory rate

Biobeat is a specialist remote monitoring company focused on wearable vital-sign monitoring. Its platform supports continuous or periodic measurement of parameters such as blood pressure, oxygen saturation, heart rate, respiratory rate, and other physiological signals.

Biobeat’s strength lies in multi-parameter monitoring. Hospital-at-home and post-acute care models require more than consumer activity tracking; they need vital signs that can support clinical decisions and escalation.

Its wearable vital-sign platform and clinical monitoring orientation support its inclusion among specialist providers.

Eko Health

• Headquarters: Oakland, United States
• Founded: 2013
• Core focus: Digital stethoscopes, AI cardiac screening, remote auscultation, cardiopulmonary monitoring

Eko Health is a specialist digital health technology company focused on connected stethoscopes, AI-supported cardiac screening, and remote auscultation. Its tools help clinicians capture, analyze, and share heart and lung sounds.

Eko’s strength lies in digitizing a core clinical examination tool. Auscultation has traditionally been analog and subjective; connected stethoscopes and AI support can improve documentation, remote review, and detection of selected abnormalities.

The company’s platform is especially relevant for primary care, cardiology screening, telehealth, and remote evaluation workflows. Its digital stethoscope and AI orientation support Tier III inclusion.

VitalConnect

• Headquarters: San Jose, United States
• Founded: 2011
• Core focus: Wearable biosensors, remote patient monitoring, vital signs, cardiac and post-acute monitoring

VitalConnect is a specialist wearable biosensor company focused on remote patient monitoring and clinical-grade vital-sign tracking. Its wearable patch technology supports monitoring of heart rate, respiratory rate, activity, posture, ECG-related signals, and other physiological data.

VitalConnect’s strength lies in medical-grade wearable patches for clinical settings. These devices can support post-discharge monitoring, hospital-at-home programs, cardiac observation, and remote clinical oversight.

Its wearable biosensor platform, clinical monitoring applications, and enterprise use cases support its inclusion among specialist providers.

WHOOP

• Headquarters: Boston, United States
• Founded: 2012
• Core focus: Wearable fitness and recovery tracking, sleep, strain, readiness, consumer health analytics

WHOOP is a leading consumer wearable platform focused on recovery, strain, sleep, heart rate variability, and performance analytics. Its screenless wearable and subscription model have built strong adoption among athletes, executives, health-conscious consumers, and performance-oriented users.

WHOOP’s strength lies in engagement and behavioral analytics. While the platform is primarily wellness-oriented, it influences how users understand recovery, stress, sleep, and training load. The company’s reported $575 million funding round at a $10.1 billion valuation shows continued investor confidence in wearable health and performance monitoring.

Regulatory scrutiny around blood pressure functionality illustrates the need to distinguish wellness analytics from medical claims. Nevertheless, WHOOP’s user base, subscription model, and recovery-focused wearable platform support its inclusion among specialist wearable health technology providers.

---

Remarks

Remote monitoring and wearable health technology providers continue to reshape healthcare by extending measurement beyond clinics and hospitals into daily life, home care, chronic disease management, post-acute monitoring, and preventive health. The category includes clinical-grade medical devices, connected chronic care platforms, ambulatory ECG systems, respiratory monitoring, smart rings, consumer wearables, and enterprise remote patient monitoring infrastructure.

The organizations recognized in this ranking represent firms whose platforms maintain sustained relevance across continuous glucose monitoring, cardiac rhythm monitoring, sleep and respiratory care, hospital-at-home monitoring, vital-sign surveillance, consumer wearable health, and longitudinal digital biomarkers. Tier classification reflects relative institutional positioning within the remote monitoring and wearable health technology sector rather than direct clinical quality rankings.

Tier classification reflects relative sensing accuracy, clinical adoption, regulatory maturity, patient engagement, enterprise integration, payer relevance, data infrastructure, and long-term platform resilience. The ranking does not constitute a medical recommendation, procurement recommendation, investment recommendation, or endorsement of any specific device or monitoring service.

---

Recognition

Organizations included in the Top 20 Remote Monitoring & Wearable Health Technology Providers 2026 ranking may request information regarding authorized use of the Ranking News designation for marketing and communications purposes.

Recognized institutions may reference the designation in:

• corporate websites
• investor communications
• marketing materials
• institutional presentations
• academic and recruitment materials

Ranking inclusion is editorially determined and independent of licensing, advertising, or commercial participation. Recognition-materials licenses govern only the use of official Ranking News / Advisory Ranking assets, approved wording, and related communications materials.

Licensing inquiries:
[email protected]